San Donato Milanese, Italy

Francesco Rodriguez

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Eniricerche S.p.a.. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Francesco Rodriguez. Retrieved from https://idiyas.com/inventor/francesco-rodriguez

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Francesco Rodriguez: Innovator in Peptide Synthesis

Introduction

Francesco Rodriguez is a notable inventor based in S. Donato Milanese, Italy. He has made significant contributions to the field of peptide synthesis, particularly through his innovative work on engineered peptide synthetases.

Latest Patents

Rodriguez holds a patent for "Engineered peptide synthetases and their use for the non-ribosomal production of modified peptides." This invention focuses on constructing functional engineered peptide synthetases that can display correct activity, enabling the non-ribosomal production of modified peptides.

Career Highlights

Francesco Rodriguez is associated with Eniricerche S.p.a., where he applies his expertise in peptide synthesis. His work has been instrumental in advancing the understanding and application of peptide synthetases in various biotechnological processes.

Collaborations

Rodriguez has collaborated with notable colleagues, including Guido Grandi and Francesca De Ferra. These partnerships have fostered a collaborative environment that enhances innovation and research in peptide synthesis.

Conclusion

Francesco Rodriguez is a pioneering inventor whose work in engineered peptide synthetases has the potential to revolutionize the production of modified peptides. His contributions to the field are significant and continue to influence biotechnological advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…